Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
189 hedge funds and large institutions have $252M invested in Immunogen Inc in 2019 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 54 increasing their positions, 61 reducing their positions, and 31 closing their positions.
417% more call options, than puts
Call options by funds: $2.46M | Put options by funds: $476K
14% more capital invested
Capital invested by funds: $221M → $252M (+$30.2M)
10% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 31
2% less funds holding
Funds holding: 192 → 189 (-3)
11% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 61
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.71M |
| 2 |
State Street
Boston,
Massachusetts
|
+$8.65M |
| 3 |
Renaissance Technologies
New York
|
+$4.25M |
| 4 |
D.E. Shaw & Co
New York
|
+$2.11M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$1.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$8.2M |
| 2 |
JP Morgan Chase
New York
|
-$3.51M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$2.27M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.89M |
| 5 |
Goldman Sachs
New York
|
-$1.88M |
IMGN Hedge Fund Activity: Q3 2019 in Review
189 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2019, worth a combined $252M — up 14% from $221M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of IMGN and 28 opened new positions — a net loss of 3 holders — while 61 trimmed existing stakes and 54 added.
The largest buyer was Vanguard Group, adding an estimated $8.71M. The largest seller was Morgan Stanley, cutting an estimated $8.2M.
- 189 institutional investors held Immunogen Inc (IMGN) as of Q3 2019, down from 192 in Q2 2019.
- Funds reported $252M of Immunogen Inc stock for Q3 2019, up 14% quarter-over-quarter.
- 28 funds opened new Immunogen Inc positions in Q3 2019 and 31 closed out, a net change of -3 holders.
- The largest Immunogen Inc buyer in Q3 2019 was Vanguard Group, an estimated $8.71M added.
- The largest Immunogen Inc seller in Q3 2019 was Morgan Stanley, an estimated $8.2M sold.
Based on aggregated 13F filings for Q3 2019.